Orion Biotech Opportunities - Warrants (15/04/2025) Receivables

Orion Biotech Opportunities - Warrants (15/04/2025)'s receivables stands at $0 as of December 2022. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orion Biotech Opportunities - Warrants (15/04/2025) reported $0 in receivables versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Orion Biotech Opportunities - Warrants (15/04/2025)'s receivables evolved across reporting periods, while the comparison chart places ORIAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.